Lars Johansson

Company: Antaros Medical AB

Job title: Chief Scientific Officer

Seminars:

Imaging A Useful Biomarker for Understanding Obesity, Insulin Resistance & Downstream End Organ Effects in Drug Development 2:00 pm

The importance of insulin resistance in the context of obesity drug development How imaging can be used to investigate body composition and end organ effects in liver, kidney, heart and muscle Imaging supporting both early and late-stage drug development decisionsRead more

day: Day One